ELIZABETH GRASS: Open Payments
NPI 1861858623 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 16 payments from 7 companies in 2025. Trend: 2023 $517 · 2024 $547 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Calliditas Therapeutics US Inc. | 2 | $47 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Apellis Pharmaceuticals, Inc. | 1 | $22 |
| Travere Therapeutics, Inc. | 1 | $15 |
Products named: FARXIGA, Kerendia, JYNARQUE, TARPEYO, ACTHAR.
Industry payments across GA — which companies pay providers there.
